IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 109 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $624,131 | -14.4% | 12,624 | -1.2% | 0.02% | -25.9% |
| Q4 2022 | $729,355 | -24.9% | 12,780 | -39.0% | 0.03% | -15.6% |
| Q3 2022 | $971,000 | +13.7% | 20,949 | -8.6% | 0.03% | +23.1% |
| Q2 2022 | $854,000 | -22.4% | 22,912 | -37.8% | 0.03% | -10.3% |
| Q1 2022 | $1,101,000 | +4.9% | 36,811 | +20.0% | 0.03% | +7.4% |
| Q4 2021 | $1,050,000 | – | 30,676 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $21,500,000 | 16.53% |
| Velan Capital Investment Management LP | 293,385 | $10,946,000 | 11.10% |
| Paradigm Biocapital Advisors LP | 667,417 | $24,901,000 | 4.96% |
| RTW INVESTMENTS, LP | 3,996,154 | $149,097,000 | 3.85% |
| Rock Springs Capital Management LP | 2,671,652 | $99,679,000 | 2.90% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $14,387,000 | 2.18% |
| Samsara BioCapital, LLC | 160,963 | $6,006,000 | 1.60% |
| Avidity Partners Management LP | 1,350,000 | $50,369,000 | 1.16% |
| Pier Capital, LLC | 123,394 | $4,604,000 | 0.78% |
| Omega Fund Management, LLC | 51,535 | $1,923,000 | 0.61% |